国药在马来西亚的实际效果，BLOOMBERG的报道 https://www.bloomberg.com/news/articles/2021-05-11/china-s-sinovac-shot-found-highly-effective-in-real-world-study Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials. Indonesia tracked 128,290 health workers in capital city Jakarta from January to March and found that the vaccine protected 98% of them from death and 96% from hospitalization as soon as seven days after the second dose, Pandji Dhewantara, a Health Ministry official who oversaw the study, said in a Wednesday press conference.
硬要选一个的话我会等一等智飞生物的三期临床结果
智飞生物是mrna疫苗吗
国内还没有mRNA吧
我妈的社区发的宣传单，上面有写智飞生物的有效率，非常高。如果还没有三期，怎么来的数据。
重组蛋白
那个应该是抗体阳转率
智飞三期还没做完就上市了 数据只能靠编 现在看来科兴稍微好一点 国药就是靠撒谎和国企背景撑着的
国药集团新发的那篇文章里面挺多料的，原来除了只让18到59岁的健康人入组之外还有别的小花招。经过中国和阿联酋方面的两轮筛选，两个疫苗组测出的阳性被排除掉了大概一半，最后做出了百分之七十多的有效率。不知道这个排除到底发生在揭盲之前还是之后，之后的话那问题就很严重了
差别都不大，科兴的也就30%有效率。
好多中成药、保健品宣传单上写着有效率高达90%以上。 这些药品保健品都有国家或省药准字号或是健字号，是受监管的。
我不懂哈。就是刚还看到国内有人发的打了智飞的手臂肿了巨大一个馒头包吓到了。
他们的临床试验流程：（1）参与者觉得自己有症状--》检测核酸 （2）核酸检测阳性的话，阿联酋专家排除一部分阳性样本（3）未被排除的阳性样本，国药专家再次评估排除一部分。（4）剩余的阳性样本用来计算有效率。
哈哈哈哈哈哈哈哈哈 这两轮都发生在揭盲前，我是不大相信的。
https://www.covidvaccine.gov.hk/zh-HK/dashboard/totalSecondDose 香港第二针的数据，辉瑞略高于科兴 现在香港在东南亚爆发的情况下，接近一个月的0确诊率
网上太多造谣的，有不同意见，可以把官方数据贴上来
同问，之前还劝老人先别打，等开发了再说。 现在看着好像变紧张了一点
https://www.bloomberg.com/news/articles/2021-05-11/china-s-sinovac-shot-found-highly-effective-in-real-world-study
Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials. Indonesia tracked 128,290 health workers in capital city Jakarta from January to March and found that the vaccine protected 98% of them from death and 96% from hospitalization as soon as seven days after the second dose, Pandji Dhewantara, a Health Ministry official who oversaw the study, said in a Wednesday press conference.